|
1
|
Sturm A and Dignass AU: Epithelial
restitution and wound healing in inflammatory bowel disease. World
J Gastroenterol. 14:348–353. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Artis D: Epithelial-cell recognition of
commensal bacteria and maintenance of immune homeostasis in the
gut. Nat Rev Immunol. 8:411–420. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hooper LV and Macpherson AJ: Immune
adaptations that maintain homeostasis with the intestinal
microbiota. Nat Rev Immunol. 10:159–169. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kreymborg K, Etzensperger R, Dumoutier L,
Haak S, Rebollo A, Buch T, Heppner FL, Renauld JC and Becher B:
IL-22 is expressed by Th17 cells in an IL-23-dependent fashion, but
not required for the development of autoimmune encephalomyelitis. J
Immunol. 179:8098–8104. 2007. View Article : Google Scholar
|
|
5
|
Satoh-Takayama N, Vosshenrich CA,
Lesjean-Pottier S, Sawa S, Lochner M, Rattis F, Mention JJ, Thiam
K, Cerf-Bensussan N, Mandelboim O, et al: Microbial flora drives
interleukin 22 production in intestinal NKp46+ cells that provide
innate mucosal immune defense. Immunity. 29:958–970. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cella M, Fuchs A, Vermi W, Facchetti F,
Otero K, Lennerz JK, Doherty JM, Mills JC and Colonna M: A human
natural killer cell subset provides an innate source of IL-22 for
mucosal immunity. Nature. 457:722–725. 2009. View Article : Google Scholar
|
|
7
|
Cupedo T, Crellin NK, Papazian N, Rombouts
EJ, Weijer K, Grogan JL, Fibbe WE, Cornelissen JJ and Spits H:
Human fetal lymphoid tissue-inducer cells are interleukin
17-producing precursors to RORC+ CD127+
natural killer-like cells. Nat Immunol. 10:66–74. 2009. View Article : Google Scholar
|
|
8
|
Luci C, Reynders A, Ivanov II, Cognet C,
Chiche L, Chasson L, Hardwigsen J, Anguiano E, Banchereau J,
Chaussabel D, et al: Influence of the transcription factor
RORgammat on the development of NKp46+ cell populations
in gut and skin. Nat Immunol. 10:75–82. 2009. View Article : Google Scholar
|
|
9
|
Sanos SL, Bui VL, Mortha A, Oberle K,
Heners C, Johner C and Diefenbach A: RORgammat and commensal
microflora are required for the differentiation of mucosal
interleukin 22-producing NKp46+ cells. Nat Immunol.
10:83–91. 2009. View Article : Google Scholar
|
|
10
|
Ouyang W, Rutz S, Crellin NK, Valdez PA
and Hymowitz SG: Regulation and functions of the IL-10 family of
cytokines in inflammation and disease. Annu Rev Immunol. 29:71–109.
2011. View Article : Google Scholar
|
|
11
|
Sawa S, Lochner M, Satoh-Takayama N,
Dulauroy S, Bérard M, Kleinschek M, Cua D, Di Santo JP and Eberl G:
RORγt+ innate lymphoid cells regulate intestinal
homeostasis by integrating negative signals from the symbiotic
microbiota. Nat Immunol. 12:320–326. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Spits H and Di Santo JP: Regulators and
effectors of immunity and tissue remodeling. Nat Immunol. 12:21–27.
2011. View Article : Google Scholar
|
|
13
|
Zenewicz LA and Flavell RA: Recent
advances in IL-22 biology. Int Immunol. 23:159–163. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zindl CL, Lai JF, Lee YK, Maynard CL,
Harbour SN, Ouyang W, Chaplin DD and Weaver CT: IL-22-producing
neutrophils contribute to antimicrobial defense and restitution of
colonic epithelial integrity during colitis. Proc Natl Acad Sci
USA. 110:12768–12773. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie MH, Aggarwal S, Ho WH, Foster J, Zhang
Z, Stinson J, Wood WI, Goddard AD and Gurney AL: Interleukin
(IL)-22, a novel human cytokine that signals through the interferon
receptor-related proteins CRF24 and IL-22R. J Biol Chem.
275:31335–31339. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kotenko SV, Izotova LS, Mirochnitchenko
OV, Esterova E, Dickensheets H, Donnelly RP and Pestka S:
Identification of the functional interleukin-22 (IL-22) receptor
complex: The IL-10R2 chain (IL-10Rbeta) is a common chain of both
the IL-10 and IL-22 (IL-10-related T cell-derived inducible factor,
IL-TIF) receptor complexes. J Biol Chem. 276:2725–2732. 2001.
View Article : Google Scholar
|
|
17
|
Pestka S, Krause CD, Sarkar D, Walter MR,
Shi Y and Fisher PB: Interleukin-10 and related cytokines and
receptors. Ann Rev Immunol. 22:929–979. 2004. View Article : Google Scholar
|
|
18
|
Sugimoto K, Ogawa A, Mizoguchi E,
Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ and Mizoguchi
A: IL-22 ameliorates intestinal inflammation in a mouse model of
ulcerative colitis. J Clin Invest. 118:534–544. 2008.PubMed/NCBI
|
|
19
|
Honda K: IL-22 from T cells: Better late
than never. Immunity. 37:952–954. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kamanaka M, Huber S, Zenewicz LA, Gagliani
N, Rathinam C, O’Connor W Jr, Wan YY, Nakae S, Iwakura Y, Hao L and
Flavell RA: Memory/effector (CD45RB(lo)) CD4 T cells are controlled
directly by IL-10 and cause IL-22-dependent intestinal pathology. J
Exp Med. 208:1027–1040. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sato T, Vries RG, Snippert HJ, van de
Wetering M, Barker N, Stange DE, van Es JH, Abo A, Kujala P, Peters
PJ and Clevers H: Single Lgr5 stem cells build crypt-villus
structures in vitro without a mesenchymal niche. Nature.
459:262–265. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sato T, van Es JH, Snippert HJ, Stange DE,
Vries RG, van den Born M, Barker N, Shroyer NF, van de Wetering M
and Clevers H: Paneth cells constitute the niche for Lgr5 stem
cells in intestinal crypts. Nature. 469:415–418. 2011. View Article : Google Scholar
|
|
23
|
Dekkers JF, Wiegerinck CL, de Jonge HR,
Bronsveld I, Janssens HM, de Winter-de Groot KM, Brandsma AM, de
Jong NW, Bijvelds MJ, Scholte BJ, et al: A functional CFTR assay
using primary cystic fibrosis intestinal organoids. Nat Med.
19:939–945. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yilmaz ÖH, Katajisto P, Lamming DW,
Gültekin Y, Bauer-Rowe KE, Sengupta S, Birsoy K, Dursun A, Yilmaz
VO, Selig M, et al: mTORC1 in the Paneth cell niche couples
intestinal stem-cell function to calorie intake. Nature.
486:490–495. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Yui S, Nakamura T, Sato T, Nemoto Y,
Mizutani T, Zheng X, Ichinose S, Nagaishi T, Okamoto R, Tsuchiya K,
et al: Functional engraftment of colon epithelium expanded in vitro
from a single adult Lgr5(+) stem cell. Nat Med. 18:618–623. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sato T and Clevers H: Growing
self-organizing mini-guts from a single intestinal stem cell:
Mechanism and applications. Science. 340:1190–1194. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
28
|
Pickert G, Neufert C, Leppkes M, Zheng Y,
Wittkopf N, Warntjen M, Lehr HA, Hirth S, Weigmann B, Wirtz S, et
al: STAT3 links IL-22 signaling in intestinal epithelial cells to
mucosal wound healing. J Exp Med. 206:1465–1472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sonnenberg GF, Fouser LA and Artis D:
Border patrol: Regulation of immunity, inflammation and tissue
homeostasis at barrier surfaces by IL-22. Nat Immunol. 12:383–390.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zenewicz LA, Yancopoulos GD, Valenzuela
DM, Murphy AJ, Stevens S and Flavell RA: Innate and adaptive
interleukin-22 protects mice from inflammatory bowel disease.
Immunity. 29:947–957. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cox JH, Kljavin NM, Ota N, Leonard J,
Roose-Girma M, Diehl L, Ouyang W and Ghilardi N: Opposing
consequences of IL-23 signaling mediated by innate and adaptive
cells in chemically induced colitis in mice. Mucosal Immunol.
5:99–109. 2012. View Article : Google Scholar
|
|
32
|
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa
SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ and
Ouyang W: Interleukin-22 mediates early host defense against
attaching and effacing bacterial pathogens. Nat Med. 14:282–289.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Basu R, O’Quinn DB, Silberger DJ, Schoeb
TR, Fouser L, Ouyang W, Hatton RD and Weaver CT: Th22 cells are an
important source of IL-22 for host protection against
enteropathogenic bacteria. Immunity. 37:1061–1075. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zenewicz LA, Yin X, Wang G, Elinav E, Hao
L, Zhao L and Flavell RA: IL-22 deficiency alters colonic
microbiota to be transmissible and colitogenic. J Immunol.
190:5306–5312. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hanash AM, Dudakov JA, Hua G, O’Connor MH,
Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, et
al: Interleukin-22 protects intestinal stem cells from
immune-mediated tissue damage and regulates sensitivity to graft
versus host disease. Immunity. 37:339–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Muñoz M, Heimesaat MM, Danker K, Struck D,
Lohmann U, Plickert R, Bereswill S, Fischer A, Dunay IR, Wolk K, et
al: Interleukin (IL)-23 mediates Toxoplasma gondii-induced
immu-nopathology in the gut via matrixmetalloproteinase-2 and IL-22
but independent of IL-17. J Exp Med. 206:3047–3059. 2009.
View Article : Google Scholar
|
|
37
|
Farin HF, Van Es JH and Clevers H:
Redundant sources of Wnt regulate intestinal stem cells and promote
formation of Paneth cells. Gastroenterology. 143:1518–1529.e7.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Batlle E, Henderson JT, Beghtel H, van den
Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering
M, Pawson T and Clevers H: Beta-catenin and TCF mediate cell
positioning in the intestinal epithelium by controlling the
expression of EphB/ephrinB. Cell. 111:251–263. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cortina C, Palomo-Ponce S, Iglesias M,
Fernández-Masip JL, Vivancos A, Whissell G, Humà M, Peiró N,
Gallego L, Jonkheer S, et al: EphB-ephrin-B interactions suppress
colorectal cancer progression by compartmentalizing tumor cells.
Nat Genet. 39:1376–1383. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wolk K, Kunz S, Witte E, Friedrich M,
Asadullah K and Sabat R: IL-22 increases the innate immunity of
tissues. Immunity. 21:241–254. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Raffatellu M, George MD, Akiyama Y,
Hornsby MJ, Nuccio SP, Paixao TA, Butler BP, Chu H, Santos RL,
Berger T, et al: Lipocalin-2 resistance confers an advantage to
Salmonella enterica serotype Typhimurium for growth and survival in
the inflamed intestine. Cell Host Microbe. 5:476–486. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Chung Y, Yang X, Chang SH, Ma L, Tian Q
and Dong C: Expression and regulation of IL-22 in the
IL-17-producing CD4+ T lymphocytes. Cell Res.
16:902–907. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liang SC, Tan XY, Luxenberg DP, Karim R,
Dunussi-Joannopoulos K, Collins M and Fouser LA: Interleukin
(IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively
enhance expression of antimicrobial peptides. J Exp Med.
203:2271–2279. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zheng Y, Danilenko DM, Valdez P, Kasman I,
Eastham-Anderson J, Wu J and Ouyang W: Interleukin-22, a T(H)17
cytokine, mediates IL-23-induced dermal inflammation and
acanthosis. Nature. 445:648–651. 2007. View Article : Google Scholar
|
|
45
|
Yan KS, Janda CY, Chang J, Zheng GXY,
Larkin KA, Luca VC, Chia LA, Mah AT, Han A, Terry JM, et al:
Non-equivalence of Wnt and R-spondin ligands during
Lgr5+ intestinal stem-cell self-renewal. Nature.
545:238–242. 2007. View Article : Google Scholar
|
|
46
|
Lindemans CA, Calafiore M, Mer telsmann A
M, O’Connor MH, Dudakov JA, Jenq RR, Velardi E, Young LF, Smith OM,
Lawrence G, et al: Interleukin-22 promotes
intestinal-stem-cell-mediated epithelial regeneration. Nature.
528:560–564. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Andoh A, Zhang Z, Inatomi O, Fujino S,
Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S,
Takayanagi A, et al: Interleukin-22, a member of the IL-10
subfamily, induces inflammatory responses in colonic subepithelial
myofibroblasts. Gastroenterology. 129:969–984. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dumoutier L, Leemans C, Lejeune D, Kotenko
SV and Renauld JC: Cutting edge: STAT activation by IL-19, IL-20
and mda-7 through IL-20 receptor complexes of two types. J Immunol.
167:3545–3549. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sabat R: IL-10 family of cytokines.
Cytokine Growth Factor Rev. 21:315–324. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wang M, Tan Z, Zhang R, Kotenko SV and
Liang P: Interleukin 24 (MDA-7/MOB-5) signals through two
heterodimeric receptors, IL-22R1/IL-20R2 and IL-20R1/IL-20R2. J
Biol Chem. 277:7341–7347. 2002. View Article : Google Scholar
|
|
51
|
Li LJ, Gong C, Zhao MH and Feng BS: Role
of interleukin-22 in inflammatory bowel disease. World J
Gastroenterol. 20:18177–18188. 2014. View Article : Google Scholar
|
|
52
|
Sugimoto S, Naganuma M, Kiyohara H, Arai
M, Ono K, Mori K, Saigusa K, Nanki K, Takeshita K, Takeshita T, et
al: Clinical efficacy and safety of oral Qing-Dai in patients with
ulcerative colitis: A single-center open-label prospective study.
Digestion. 93:193–201. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Low D, Mino-Kenudson M and Mizoguchi E:
Recent advancement in understanding colitis-associated
tumorigenesis. Inflamm Bowel Dis. 20:2115–2123. 2014. View Article : Google Scholar : PubMed/NCBI
|
